in this issue
Regions :: Western Europe
Merck KGaA reports lower second-quarter net income, confirms outlook
August 13, 2014 | Natasha Alperowicz
Merck KGaA today reported a 4% decline in second-quarter net income, to €303.3 million ($404.9 million). Acquisition-related one-time items, lower royalty, license and commission income, and negative foreign exchange effects were responsible for the decline. Ebitda before one-time items was up 2.3%, to €846 million, on 2% higher sales of €2.8 billion. The company has confirmed full-year forecast despite negative currency effects and lower royalty, license, and commission income. Merck expects sales to increase to about €10.9–11.1 billion...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee